Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Britain Courts Anthropic Amid US Defense Department Dispute 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
LOS ANGELES, Sept. 11, 2017 -- Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced that it has partnered with management to acquire Capsa Healthcare (“Capsa” or the “Company”). Capsa is a leading provider of mobile workstations, medication management products, and pharmacy automation solutions for healthcare settings worldwide. The Company’s workflow solutions increase efficiency for over 3,000 customers, including leading health systems, senior care communities and major retail and institutional pharmacies. Capsa is headquartered in Portland, OR and has additional production facilities in Columbus, OH and Agua Prieta, Mexico.
The investment in Capsa will be the first investment from Levine Leichtman Capital Partners VI, L.P. According to Aaron Perlmutter, Partner of LLCP, “We are excited to partner with Andrew Sherrill, CEO, and the rest of the Capsa management team, who have successfully built a market leading company in an attractive segment of the healthcare industry. We are looking forward to working with Andrew and his team to continue providing innovative solutions to a growing and evolving healthcare landscape.”
The Company’s management team, led by Andrew Sherrill, will acquire a meaningful ownership stake in the Company in connection with the transaction. Andrew Sherrill commented, “My team and I are very excited to partner with LLCP as Capsa seeks to enhance its market-leading position across the healthcare ecosystem. LLCP’s experience across sectors including highly-engineered products and healthcare services – the intersection of which Capsa is situated – as well as LLCP’s operational and deal origination resources, will be critical to the continued growth of the Company.”
LLCP was advised by Kirkland & Ellis LLP. Senior financing was provided by Midcap Financial, NewStar Financial and Madison Capital.
About Levine Leichtman Capital Partners
LLCP is a Los Angeles, California based private investment firm that has managed approximately $9.0 billion of institutional capital since its inception. LLCP invests in middle market companies located in the United States and Europe. LLCP is currently making new investments through Levine Leichtman Capital Partners VI, L.P., LLCP Lower Middle Market Fund, L.P., Levine Leichtman Capital Partners Private Capital Solutions, L.P., Levine Leichtman Capital Partners Europe, L.P. and LLCP Co-Investment Fund, L.P. LLCP has offices in Los Angeles, New York, Dallas, Chicago, London and The Hague.
Contact: David Wolmer
Phone: 310-275-5335
